High-dose norepinephrine treatment: Determinants of mortality and futility in critically ill patients

American Journal of Critical Care

Volumn 22, Issue 1, 2013, Pages 22-32

  Döpp Zemel, Donna ^a   Groeneveld, Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; VASOCONSTRICTOR AGENT;

AGED; ARTICLE; CRITICAL ILLNESS; DOSE RESPONSE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SHOCK; STATISTICS; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICAL FUTILITY; MIDDLE AGED; NOREPINEPHRINE; RETROSPECTIVE STUDIES; SHOCK; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 84873105438     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2013748     Document Type: Article

References (29)

1. Levy B, Bollaert PE, Charpentier C, et al. A comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 1997;23(3):282-287.
2. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32(11 suppl):455-465.
3. Annane D, Vignon P, Renault A, et al; CATS study group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007;370(9588):676-684.
4. Dellinger RP, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
5. Myburgh JA, Higgins A, Jovanosvka A, et al; CAT study investigators. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008; 34:2226-2234.
6. Russell JA, Walley KR, Singer J, et al; VASST investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877-887.
7. Havel C, Arrich J, Losert H, Gamper G, Müllner M, Herkner H. Vasopressors for hypotensive shock. Cochrane Library Web site. http://onlinelibrary.wiley.com/doi/10.1002/14651858 .CD003709.pub3/abstract. Published May 11, 2011. Accessed October 15, 2012.
8. De Backer D, Biston P, Devriendt J, et al; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789.
9. Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010;33(4):375-380.
10. Levy B, Perez P, Perny J, Thivilier C, Gerard A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: a prospective, randomized pilot study. Crit Care Med. 2011;39(3):450-455.
11. De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40:725-730.
12. Layish DT, Tapson VF. Pharmacologic hemodynamic support in massive pulmonary embolism. Chest. 1997;111:218-224.
13. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000;28:2758-2765.
14. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006;34(3):589-597.
15. Katz JN, Stebbins AL, Alexander JH, et al; TRIUMPH investigators. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J. 2009; 158:680-687.
16. Dünser MW, Takala J, Ulmer H, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009; 35(7):1225-1233.
17. Jenkins C, Gomerall C, Leung P, Joynt G. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesth Intensive Care. 2009;37(2):286-289.
18. Benbenishty J, Weissman C, Sprung CL, Brodsky-Israeli M, Weiss Y. Characteristics of patients receiving vasopressors. Heart Lung. 2011;40(3):247-252.
19. Abid O, Akça S, Haji-Michael P, Vincent JL. Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med. 2000; 28(4):947-949.
20. Subramanian S, Yilmaz M, Rehman A, Hubmayr RD, Afessa B, Gajic O. Liberal vs restrictive vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study. Intensive Care Med. 2008;34(1):157-162.
21. Benchekroune S, Karpati PC, Berton C, et al. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock. J Trauma. 2008;64(5):1188-1195.
22. Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC; Portugese Community-Acquired Sepsis Study group. Influence of vasopressor agent in septic shock mortality. results from the Portugese Community-Acquired Sepsis Study (SACiUCI study). Crit Care Med. 2009;37(2):410-416.
23. Dünser MW, Ruokonen E, Pettilä V, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13(6):R181.
24. Levy B, Perez P, Gibot S, Gerard A. Increased muscle-to-serum lactate gradient predicts progression towards septic shock in septic patients. Intensive Care Med. 2010;36:1703-1709.
25. World Health Organization. International Classification of Diseases. 10th ed, 2nd revision. Geneva, Switzerland: World Health Organization; 2004.
26. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP /ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4): 1250-1256.
27. Van der Voort PHJ, Bakhshi-Raiez F, de Lange DW, et al. Trends in time: results from the NICE registry. Neth J Crit Care. 2009;13(1):8-15.
28. Bellomo R, Wan L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med. 2008;36(4 suppl):S179-S186.
29. Gabbay E, Calvo-Broce J, Meyer KB, Trikalinos TA, Cohen J, Kent DM. The empirical basis for determinations of medical futility. J Gen Intern Med. 2010;25(10):1083-1089.